Royal DSM N.V. (DSM) - Financial and Strategic SWOT Analysis Review

Published: June 2013

Publisher: GlobalData

Product ref: 173122

Pages: 63

Format: PDF

Delivery: Immediate download

Email details: Forward this to a colleague

Satisfaction guarantee: Yes - details here

Price guarantee: Yes - details here

Price: $ 125.00

Report description

Royal DSM N.V. (DSM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Royal DSM N.V. (DSM) is a global life sciences and materials sciences company. It primarily focuses health, nutrition and materials sectors. The company offers a wide range of products, ranging from anti-invectives, polyesters, vitamins, to oil and gas across diverse end markets. It offers its products and services to animal and human health and nutrition, personal care, pharmaceuticals, automotive, medical materials, food and beverages, packaging, electrical and electronics, coatings and paint, alternative energy, housing, and life protection markets.

Royal DSM N.V. Key Recent Developments

Jun 05, 2013: DSM Announces Availability Of Fruitflow And resVida Health Ingredients In Bricker Labs's OptiFlow Capsules
May 02, 2013: DSM Reports Revenue Of €2.4 Billion In Q1 2013
Mar 11, 2013: Oceans Omega Signs Supply Agreement With DSM Nutritional Products
Nov 06, 2012: DSM Reports Revenue Of €2.3 Billion In Q3 2012
Oct 24, 2012: DSM Pharma Signs Biologics Contract Manufacturing Agreement With Paranta Biosciences

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of contents

Section 1 - About the Company
Royal DSM N.V. - Key Facts
Royal DSM N.V. - Key Employees
Royal DSM N.V. - Key Employee Biographies
Royal DSM N.V. - Major Products and Services
Royal DSM N.V. - Key Operational Summary
Royal DSM N.V. - History
Royal DSM N.V. - Company Statement
Royal DSM N.V. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Royal DSM N.V. - Key Manufacturing Facilities
Section 2 – Company Analysis
Royal DSM N.V. - Business Description
Business Description - Nutrition
Nutrition - Overview
Nutrition - Financials
Nutrition - Capital Expenditure
Business Description - Other Activities
Other Activities - Overview
Other Activities - Financials
Other Activities - Capital Expenditure
Business Description - Performance Materials
Performance Materials - Overview
Performance Materials - Financials
Performance Materials - Capital Expenditure
Business Description - Pharma
Pharma - Overview
Pharma - Financials
Pharma - Capital Expenditure
Business Description - Polymer Intermediates
Polymer Intermediates - Overview
Polymer Intermediates - Financials
Polymer Intermediates - Capital Expenditure
Royal DSM N.V. - SWOT Analysis
SWOT Analysis - Overview
Royal DSM N.V. - Strengths
Strength - Market Leadership
Strength - Awards and Recognition
Strength - Widespread Business Operations
Royal DSM N.V. - Weaknesses
Weakness - Fall in Working Capital
Weakness - Debt Obligations
Royal DSM N.V. - Opportunities
Opportunity - Key Initiatives
Opportunity - Growing Paint and Coatings Industry
Opportunity - Strategic Acquisitions
Royal DSM N.V. - Threats
Threat - Challenge of Environmental Regulations
Threat - Competitive Landscape
Threat - M&A Holds Risk of Inefficient Integration
Royal DSM N.V. - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences, Oil & Gas Financial Deals and Alliances
Royal DSM N.V., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Royal DSM N.V., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Royal DSM N.V., Medical Equipment, Deals By Year, 2007 to YTD 2013
Royal DSM N.V., Medical Equipment, Deals By Type, 2007 to YTD 2013
Royal DSM N.V., Petrochemicals, Deals By Year, 2007 to YTD 2013
Royal DSM N.V., Petrochemicals, Deals By Type, 2007 to YTD 2013
Royal DSM N.V., Oil & Gas, Deals By Year, 2007 to YTD 2013
Royal DSM N.V., Oil & Gas, Deals By Type, 2007 to YTD 2013
Royal DSM N.V., Power, Deals By Year, 2007 to YTD 2013
Royal DSM N.V., Power, Deals By Type, 2007 to YTD 2013
Royal DSM N.V., Recent Deals Summary
Section 5 – Company’s Recent Developments
Royal DSM N.V., Recent Developments
Jun 05, 2013: DSM Announces Availability Of Fruitflow And resVida Health Ingredients In Bricker Labs's OptiFlow Capsules
May 02, 2013: DSM Reports Revenue Of €2.4 Billion In Q1 2013
Mar 11, 2013: Oceans Omega Signs Supply Agreement With DSM Nutritional Products
Nov 06, 2012: DSM Reports Revenue Of €2.3 Billion In Q3 2012
Oct 24, 2012: DSM Pharma Signs Biologics Contract Manufacturing Agreement With Paranta Biosciences
Aug 07, 2012: DSM Reports Revenue Of €2.3 Billion In Q2 2012
Jun 19, 2012: DSM Obtains Patents For Proprietary XD Biomanufacturing Technology
Jun 18, 2012: DSM Signs Agreement With Major Pharma Company For Contract Manufacturing Services
Jun 05, 2012: DSM Enzymes Qualified By DONG Energy For Biomass To Cellulosic Bio-ethanol Refineries
May 08, 2012: DSM Reports Net Sales Of €2.3 Billion In Q1 2012
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Royal DSM N.V., Key Facts
Royal DSM N.V., Key Employees
Royal DSM N.V., Key Employee Biographies
Royal DSM N.V., Major Products and Services
Royal DSM N.V., Key Operational Summary, 2011
Royal DSM N.V., History
Royal DSM N.V., Other Locations
Royal DSM N.V., Subsidiaries
Royal DSM N.V., Key Manufacturing Facilities
Royal DSM N.V., Key Competitors
Royal DSM N.V., Ratios based on current share price
Royal DSM N.V., Annual Ratios
Royal DSM N.V., Interim Ratios
Royal DSM N.V., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Royal DSM N.V., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Royal DSM N.V., Medical Equipment, Deals By Year, 2007 to YTD 2013
Royal DSM N.V., Medical Equipment, Deals By Type, 2007 to YTD 2013
Royal DSM N.V., Petrochemicals, Deals By Year, 2007 to YTD 2013
Royal DSM N.V., Petrochemicals, Deals By Type, 2007 to YTD 2013
Royal DSM N.V., Oil & Gas, Deals By Year, 2007 to YTD 2013
Royal DSM N.V., Oil & Gas, Deals By Type, 2007 to YTD 2013
Royal DSM N.V., Power, Deals By Year, 2007 to YTD 2013
Royal DSM N.V., Power, Deals By Type, 2007 to YTD 2013
Royal DSM N.V., Recent Deals Summary
Currency Codes
Units
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Royal DSM N.V., Performance Chart (2008 - 2012)
Royal DSM N.V., Ratio Charts
Royal DSM N.V., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Royal DSM N.V., Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013
Royal DSM N.V., Medical Equipment, Deals By Year, 2007 to YTD 2013
Royal DSM N.V., Medical Equipment, Deals by Type, 2007 to YTD 2013
Royal DSM N.V., Petrochemicals, Deals By Year, 2007 to YTD 2013
Royal DSM N.V., Petrochemicals, Deals by Type, 2007 to YTD 2013
Royal DSM N.V., Oil & Gas, Deals By Year, 2007 to YTD 2013
Royal DSM N.V., Oil & Gas, Deals by Type, 2007 to YTD 2013
Royal DSM N.V., Power, Deals By Year, 2007 to YTD 2013
Royal DSM N.V., Power, Deals by Type, 2007 to YTD 2013 50

Price: $ 125.00

Related research categories

By company: Royal DSM N.V., SWOT analysis